T-cell therapy
Keeping tabs on pharma: Landmark new drug approvals and Sanofi’s diversity push
April 05 by Leila HawkinsPharma IQ’s latest round-up has the latest drug approvals for Gilead and AstraZeneca
UCI announces immunotherapy technique to specifically target tumor cells
November 12 by Pharmaceuticals & Biotechnology EditorUCI and Caltech's latest "lab on a chip" technology could be used to create individualized treatments for cancer